160 related articles for article (PubMed ID: 27485577)
1. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial.
Arenal A; Proclemer A; Kloppe A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
Europace; 2016 Nov; 18(11):1719-1725. PubMed ID: 27485577
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.
Gasparini M; Proclemer A; Klersy C; Kloppe A; Lunati M; Ferrer JB; Hersi A; Gulaj M; Wijfels MC; Santi E; Manotta L; Arenal A
JAMA; 2013 May; 309(18):1903-11. PubMed ID: 23652522
[TBL] [Abstract][Full Text] [Related]
3. Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial.
Gasparini M; Lunati MG; Proclemer A; Arenal A; Kloppe A; Martínez Ferrer JB; Hersi AS; Gulaj M; Wijffels MCE; Santi E; Manotta L; Varma N
JACC Clin Electrophysiol; 2017 Nov; 3(11):1275-1282. PubMed ID: 29759624
[TBL] [Abstract][Full Text] [Related]
4. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.
Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X
J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming the tachycardia parameters with long-detection strategy in patients with pre-existing implantable cardioverter-defibrillator.
Bozyel S; Aktas M; Mutluer FO; Guler TE; Dervis E; Argan O; Celikyurt U; Agir A; Vural A
Acta Cardiol; 2019 Jun; 74(3):246-251. PubMed ID: 30058473
[No Abstract] [Full Text] [Related]
6. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
[TBL] [Abstract][Full Text] [Related]
8. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.
Wathen MS; Sweeney MO; DeGroot PJ; Stark AJ; Koehler JL; Chisner MB; Machado C; Adkisson WO;
Circulation; 2001 Aug; 104(7):796-801. PubMed ID: 11502705
[TBL] [Abstract][Full Text] [Related]
9. Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks.
Joung B; Lexcen DR; Ching CK; Silver MT; Piccini JP; Sterns LD; Rabinovich R; Pickett RA; Liu S; Brown ML; Cheng A
Heart Rhythm; 2020 Jan; 17(1):98-105. PubMed ID: 31369873
[TBL] [Abstract][Full Text] [Related]
10. The benefit of a second burst antitachycardia sequence for fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
Anguera I; Dallaglio P; Sabaté X; Nuñez E; Gracida M; Di Marco A; Sugrañes G; Cequier A
Pacing Clin Electrophysiol; 2014 Apr; 37(4):486-94. PubMed ID: 24215374
[TBL] [Abstract][Full Text] [Related]
11. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
[TBL] [Abstract][Full Text] [Related]
12. Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT.
Schuger C; Daubert JP; Zareba W; Rosero S; Yong P; McNitt S; Kutyifa V
Heart Rhythm; 2021 Mar; 18(3):399-403. PubMed ID: 33232811
[TBL] [Abstract][Full Text] [Related]
13. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
[TBL] [Abstract][Full Text] [Related]
14. Shock Reduction With Antitachycardia Pacing Before and During Charging for Fast Ventricular Tachycardias in Patients With Implantable Defibrillators.
Dallaglio PD; Anguera I; Martínez Ferrer JB; Pérez L; Viñolas X; Porres JM; Fontenla A; Alzueta J; Martínez JG; Rodríguez A; Basterra N; Sabaté X
Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):709-717. PubMed ID: 29242102
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients.
Hayashi Y; Takagi M; Kakihara J; Sakamoto S; Doi A; Sugioka K; Hanatani A; Yoshiyama M
Heart Vessels; 2017 Feb; 32(2):175-185. PubMed ID: 27259484
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of anti-tachycardia pacing for terminating fast ventricular tachycardia in Japanese implantable cardioverter defibrillator patients. Primary results of the SATISFACTION study.
Watanabe T; Inoue K; Kashiwase K; Mine T; Hirooka K; Shutta R; Okuyama Y; Mizuno H; Shimoshige S; Takenaka S; Sumiyoshi T; Yambe Y; Shirota K; Nitta J; Ito M; Keida T; Nanto S
Circ J; 2014; 78(11):2643-50. PubMed ID: 25262963
[TBL] [Abstract][Full Text] [Related]
17. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial.
Sullivan RM; Russo AM; Berg KC; Stolen KQ; Seth M; Perschbacher D; Day JD; Olshansky B
Heart Rhythm; 2012 Mar; 9(3):351-8. PubMed ID: 22016074
[TBL] [Abstract][Full Text] [Related]
18. Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
Sivagangabalan G; Eshoo S; Eipper VE; Thiagalingam A; Kovoor P
Pacing Clin Electrophysiol; 2008 Sep; 31(9):1095-9. PubMed ID: 18834458
[TBL] [Abstract][Full Text] [Related]
19. Antitachycardia pacing for shock prevention in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
Dallaglio PD; di Marco A; Moreno Weidmann Z; Perez L; Alzueta J; García-Alberola A; Fernandez-Lozano I; Díaz-Infante E; Rodriguez A; Basterra N; Calvo D; Rodriguez Garcia M; Aceña M; Anguera I
Heart Rhythm; 2020 Jul; 17(7):1084-1091. PubMed ID: 32113896
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study.
Martins RP; Blangy H; Muresan L; Freysz L; Groben L; Zinzius PY; Schwartz J; Sellal JM; Aliot E; Sadoul N
Europace; 2012 Oct; 14(10):1457-64. PubMed ID: 22547765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
